AcuraStem

About AcuraStem

AcuraStem is a patient-based biotechnology company focused on pioneering treatments for neurodegenerative diseases, such as sporadic ALS and FTD, using their proprietary iNeuroRx(r) disease-modeling platform to discover novel, effective, and broadly-acting treatments.

Products & Services

iNeuroRx(r) Platform:A best-in-class disease-modeling platform used to develop treatments for neurodegenerative diseases by accurately recapitulating disease processes in individual patient models.

Therapeutics for ALS and FTD:Developing disease-modifying treatments, including UNC13A candidate AS-241 and antisense oligonucleotides (ASOs) for ALS and FTD.

Specialties

Neurodegenerative Disease Modeling Patient-Based Therapeutics ALS and FTD Treatment Development RNA Therapies Antisense Oligonucleotides (ASOs)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 4000000 MR: - FA: 4 million FAN: 4000000	D: 2024-09-03 FD: 2024-09-03	1 investors
2	RT: Grant T: - FT: Grant	A: 7000000 MR: - FA: nearly $7 million FAN: 7000000	D: 2024-01-30 FD: 2024-01-30	2 investors

Grant Latest

2024-09-03

$4.0M

1 investor (Pro only)

Grant 2024-01-30

$7.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Samuel V. Alworth

Co-founder and CEO

M

Marcel van der Brug

Chief Scientific Officer

W

Wen-Hsuan Chang

Associate Vice President, Discovery and Early Development

M

Min Jeong Lim

Senior Director, Translational Science

J

Justin Ichida

Associate Professor of Stem Cell Biology and Regenerative Medicine and Director of the Choi Therapeutic Screening Center

P

Paul August

Co-founder, AcuraStem

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

AcuraStem Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised